| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 73, 865-876, Copyright © 1986 by American Heart Association
JE Gage, OM Hess, T Murakami, M Ritter, J Grimm and HP Krayenbuehl
To study the vasomotility of normal and diseased coronary arteries during
dynamic exercise, symptom-limited supine bicycle exercise during cardiac
catheterization was performed by 18 patients with classic angina pectoris.
The cardiovascular response was assessed by hemodynamic measurements and
computer-assisted determination of normal and stenotic coronary artery
luminal areas from biplane coronary angiograms made before, during, and
after exercise. After baseline measurements were recorded, 12 patients
(group 1) performed bicycle exercise for 3.4 min (mean), reaching a maximum
workload of 81 W (mean); at the end of exercise they received 1.6 mg
sublingual nitroglycerin. After measurements at rest in six other patients
(group 2), 0.1 mg intracoronary nitroglycerin was given, followed by
exercise (3.8 min, 96 W; NS) and sublingual nitroglycerin as in group 1.
During exercise in group 1, luminal area of the coronary stenosis decreased
to 71% of resting levels (p less than .001), while area of the normal
coronary artery increased to 123% of control (p less than .001). After
sublingual nitroglycerin at the end of exercise, area of the normal vessel
further increased to 140% of control (p less than .001), while luminal area
of the stenosis dilated to 112% of resting levels (p less than .001 vs
exercise, NS vs rest). Pretreatment with intracoronary nitroglycerin
increased both normal (121%; p less than .05) and stenotic (122%; p less
than .05) luminal areas, while preventing the previously observed narrowing
of stenosis during exercise (114%; NS). Exercise resulted in a similar
heart rate-systolic pressure product and caused angina pectoris in
two-thirds of the patients in each group. However, patients pretreated with
intracoronary nitroglycerin (group 2) had a lower mean pulmonary arterial
pressure during maximum exercise (35 mm Hg) than those patients (group 1)
not receiving pretreatment (47 mm Hg; p less than .001). Group 2 patients
reached a percentage of their predicted work capacity (65%) that was about
the same as that during previous upright bicycle exercise (71%; NS), while
group 1 patients had a significantly lower work capacity (51% of predicted)
than that before catheterization (82%; p less than .001). Hence, narrowing
of coronary artery stenosis during dynamic exercise is attributable to
active vasoconstriction due to its reversibility by preexercise
intracoronary nitroglycerin. Patients who did not experience narrowing of
stenosis during exercise (group 2) had less evidence of myocardial ischemia
(lower mean pulmonary arterial pressure) and maintained their work
capacity.(ABSTRACT TRUNCATED AT 400 WORDS)
ARTICLES
Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin
This article has been cited by other articles:
 |
|
 |
|
  M. Togni, S. Windecker, R. Cocchia, P. Wenaweser, S. Cook, M. Billinger, B. Meier, and O. M. Hess Sirolimus-Eluting Stents Associated With Paradoxic Coronary Vasoconstriction J. Am. Coll. Cardiol., July 19, 2005; 46(2): 231 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V.-P. Valkonen, T.-P. Tuomainen, and R. Laaksonen DDAH gene and cardiovascular risk Vascular Medicine, July 1, 2005; 10(1_suppl): S45 - S48. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Abrams Chronic Stable Angina N. Engl. J. Med., June 16, 2005; 352(24): 2524 - 2533. [Full Text] [PDF]
|
|
|
|
|
|
V.-P. Valkonen, T.-P. Tuomainen, and R. Laaksonen DDAH gene and cardiovascular risk Vascular Medicine, May 1, 2005; 10(2_suppl): S45 - S48. [Abstract] [PDF]
|
|
|
|
 |
|
 S Jadhav, J Petrie, W Ferrell, S Cobbe, and N Sattar Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation? Heart, December 1, 2004; 90(12): 1379 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Togni, S. Windecker, P. Wenaweser, D. Tueller, A. Kaisaier, W. Maier, B. Meier, and O. M. Hess Deleterious Effect of Coronary Brachytherapy on Vasomotor Response to Exercise Circulation, July 13, 2004; 110(2): 135 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Thadani Current Medical Management of Chronic Stable Angina Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S11 - S29. [Abstract] [PDF]
|
|
|
|
|
|
E. Barbato, J. Bartunek, E. Wyffels, W. Wijns, G. R. Heyndrickx, and B. De Bruyne Effects of intravenous dobutamineon coronary vasomotion in humans J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1596 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Kern Dobutamine and the coronary vasomotion paradox J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1602 - 1604. [Full Text] [PDF]
|
|
|
|
|
|
D Tousoulis, G J Davies, C Tentolouris, T Crake, G Goumas, C Stefanadis, and P Toutouzas Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries Heart, May 1, 2003; 89(5): 531 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. O. Bonetti, L. O. Lerman, and A. Lerman Endothelial Dysfunction: A Marker of Atherosclerotic Risk Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 168 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. J. Halcox, K. R. A. Nour, G. Zalos, R. Mincemoyer, M. A. Waclawiw, C. E. Rivera, G. Willie, S. Ellahham, and A. A. Quyyumi The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1232 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Sposito and M. J. Chapman Statin Therapy in Acute Coronary Syndromes: Mechanistic Insight Into Clinical Benefit Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1524 - 1534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Maier, S. Windecker, A. Kung, R. Lutolf, F. R. Eberli, B. Meier, and O. M. Hess Exercise-Induced Coronary Artery Vasodilation Is Not Impaired by Stent Placement Circulation, May 21, 2002; 105(20): 2373 - 2377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Simula, E. Vanninen, L. Viitanen, A. Kareinen, S. Lehto, P. Pajunen, M. Syvanne, J. Kuikka, M. Laakso, and J. Hartikainen Cardiac Adrenergic Innervation Is Affected in Asymptomatic Subjects with Very Early Stage of Coronary Artery Disease J. Nucl. Med., January 1, 2002; 43(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. De Bruyne, F. Hersbach, N. H.J. Pijls, J. Bartunek, J.-W. Bech, G. R. Heyndrickx, K. L. Gould, and W. Wijns Abnormal Epicardial Coronary Resistance in Patients With Diffuse Atherosclerosis but "Normal" Coronary Angiography Circulation, November 13, 2001; 104(20): 2401 - 2406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Prasad, J. P. J. Halcox, M. A. Waclawiw, and A. A. Quyyumi Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1089 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Prasad, R. Mincemoyer, and A. A. Quyyumi Anti-ischemic effects of angiotensin- converting enzyme inhibition in hypertension J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1116 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Wilson Looks Aren't Everything : FFR B4 U PTCA Circulation, June 19, 2001; 103(24): 2873 - 2875. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Haegeli, K. Quitzau, T.F. Luscher, and Steering Committee and the Investigators of the EN From endothelial dysfunction to clinical events Concept and update on the ENCORE trials Eur. Heart J. Suppl., May 1, 2001; 3(suppl_B): B12 - B19. [Abstract] [PDF]
|
|
|
|
|
|
W. J. Kop, D. S. Krantz, R. H. Howell, M. A. Ferguson, V. Papademetriou, D. Lu, J. J. Popma, J. F. Quigley, M. Vernalis, and J. S. Gottdiener Effects of mental stress on coronary epicardial vasomotion and flow velocity in coronary artery disease: relationship with hemodynamic stress responses J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1359 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. KINGWELL Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease FASEB J, September 1, 2000; 14(12): 1685 - 1696. [Abstract] [Full Text]
|
|
|
|
|
|
G. Heusch, D. Baumgart, P. Camici, W. Chilian, L. Gregorini, O. Hess, C. Indolfi, and O. Rimoldi {alpha}-Adrenergic Coronary Vasoconstriction and Myocardial Ischemia in Humans Circulation, February 15, 2000; 101(6): 689 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Drexler Nitric oxide and coronary endothelial dysfunction in humans Cardiovasc Res, August 15, 1999; 43(3): 572 - 579. [Full Text] [PDF]
|
|
|
|
|
|
P. Voci, G. Testa, G. Plaustro, and Q. Caretta Coronary Doppler intensity changes during handgrip: a new method to detect coronary vasomotor tone in coronary artery disease J. Am. Coll. Cardiol., August 1, 1999; 34(2): 428 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Luscher and G. Noll Is It All in the Genes... ? : Nitric Oxide Synthase and Coronary Vasospasm Circulation, June 8, 1999; 99(22): 2855 - 2857. [Full Text] [PDF]
|
|
|
|
|
|
B. K. Julius, G. Vassalli, L. Mandinov, and O. M. Hess Alpha-adrenoceptor blockade prevents exercise-induced vasoconstriction of stenotic coronary arteries J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1499 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Prasad, S. Husain, and A. A. Quyyumi Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: A potential role of bradykinin J. Am. Coll. Cardiol., March 1, 1999; 33(3): 796 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Kal, I. Vergroesen, and H. B. van Wezel The Effect of Nitroglycerin on Pacing-Induced Changes in Myocardial Oxygen Consumption and Metabolic Coronary Vasodilation in Patients with Coronary Artery Disease Anesth. Analg., February 1, 1999; 88(2): 271 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Bache Vasodilator Reserve : A Functional Assessment of Coronary Health Circulation, September 29, 1998; 98(13): 1257 - 1260. [Full Text] [PDF]
|
|
|
|
|
|
J. Frielingsdorf, P. Kaufmann, T. Suter, R. Hug, and O. M. Hess Percutaneous Transluminal Coronary Angioplasty Reverses Vasoconstriction of Stenotic Coronary Arteries in Hypertensive Patients Circulation, September 22, 1998; 98(12): 1192 - 1197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Cannon III Role of nitric oxide in cardiovascular disease: focus on the endothelium Clin. Chem., August 1, 1998; 44(8): 1809 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bhagat Endothelial function and myocardial infarction Cardiovasc Res, August 1, 1998; 39(2): 312 - 317. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kaufmann, J. Frielingsdorf, L. Mandinov, C. Seiler, R. Hug, and O. M. Hess Reversal of Abnormal Coronary Vasomotion by Calcium Antagonists in Patients With Hypercholesterolemia Circulation, April 14, 1998; 97(14): 1348 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Olausson, H. Magnusdottir, L. Lurje, B. Wennerblom, H. Emanuelsson, and S.-E. Ricksten Anti-Ischemic and Anti-Anginal Effects of Thoracic Epidural Anesthesia Versus Those of Conventional Medical Therapy in the Treatment of Severe Refractory Unstable Angina Pectoris Circulation, October 7, 1997; 96(7): 2178 - 2182. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. A. Rapps, M. Sturek, A. W. Jones, and J. L. Parker Altered reactivity of coronary arteries located distal to a chronic coronary occlusion Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1879 - H1887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sambuceti, M. Marzilli, P. Marraccini, J. Schneider-Eicke, E. Gliozheni, O. Parodi, and A. L'Abbate Coronary Vasoconstriction During Myocardial Ischemia Induced by Rises in Metabolic Demand in Patients With Coronary Artery Disease Circulation, June 17, 1997; 95(12): 2652 - 2659. [Abstract] [Full Text]
|
|
|
|
|
|
B. K. Julius, M. Spillmann, G. Vassalli, B. Villari, F. R. Eberli, and O. M. Hess Angina Pectoris in Patients With Aortic Stenosis and Normal Coronary Arteries: Mechanisms and Pathophysiological Concepts Circulation, February 18, 1997; 95(4): 892 - 898. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Marchioli, R. M. Marfisi, F. Carinci, and G. Tognoni Meta-analysis, Clinical Trials, and Transferability of Research Results Into Practice: The Case of Cholesterol-Lowering Interventions in the Secondary Prevention of Coronary Heart Disease Arch Intern Med, June 10, 1996; 156(11): 1158 - 1172. [Abstract] [PDF]
|
|
|
|
|
|
D. S. Krantz, W. J. Kop, F. H. Gabbay, A. Rozanski, M. Barnard, J. Klein, Y. Pardo, and J. S. Gottdiener Circadian Variation of Ambulatory Myocardial Ischemia : Triggering by Daily Activities and Evidence for an Endogenous Circadian Component Circulation, April 1, 1996; 93(7): 1364 - 1371. [Abstract] [Full Text]
|
|
|
|
|
|
J. Frielingsdorf, C. Seiler, P. Kaufmann, G. Vassalli, T. Suter, and O. M. Hess Normalization of Abnormal Coronary Vasomotion by Calcium Antagonists in Patients With Hypertension Circulation, April 1, 1996; 93(7): 1380 - 1387. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Zeiher, V. Schachinger, and J. Minners Long-term Cigarette Smoking Impairs Endothelium-Dependent Coronary Arterial Vasodilator Function Circulation, September 1, 1995; 92(5): 1094 - 1100. [Abstract] [Full Text]
|
|
|
|
|
|
A. A. Quyyumi, N. Dakak, N. P. Andrews, D. M. Gilligan, J. A. Panza, and R. O. Cannon III Contribution of Nitric Oxide to Metabolic Coronary Vasodilation in the Human Heart Circulation, August 1, 1995; 92(3): 320 - 326. [Abstract] [Full Text]
|
|
|
|
|
|
G. Vassalli, P. Kaufmann, B. Villari, M. Jakob, H. Boj, W. Kiowski, and O. M. Hess Reduced Epicardial Coronary Vasodilator Capacity in Patients With Left Ventricular Hypertrophy Circulation, June 15, 1995; 91(12): 2916 - 2923. [Abstract] [Full Text]
|
|
|
|
|
|
J. Abrams The Role of Nitrates in Coronary Heart Disease Arch Intern Med, February 27, 1995; 155(4): 357 - 364. [Abstract] [PDF]
|
|
|
|
|
|
T. J. Anderson, I. T. Meredith, A. C. Yeung, B. Frei, A. P. Selwyn, and P. Ganz The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion N. Engl. J. Med., February 23, 1995; 332(8): 488 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. N. Levine, J. F. Keaney, and J. A. Vita Cholesterol Reduction in Cardiovascular Disease -- Clinical Benefits and Possible Mechanisms N. Engl. J. Med., February 23, 1995; 332(8): 512 - 521. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Abrams A Reappraisal of Nitrate Therapy JAMA, January 15, 1988; 259(3): 396 - 401. [Abstract] [PDF]
|
|